Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.
FAQs
DeFi Technologies (DEFTF) Stock Forecast, Price Targets and Analysts Predictions - TipRanks.com? ›
Average Price Target
Is DEFTF a good stock to buy? ›Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for DeFi Technologies Inc. stock to perform well in the short-term.
What is the price prediction for $NIO stock? ›NIO Stock 12 Month Forecast
Based on 11 Wall Street analysts offering 12 month price targets for Nio in the last 3 months. The average price target is $5.97 with a high forecast of $8.00 and a low forecast of $4.00. The average price target represents a 7.57% change from the last price of $5.55.
AI Stock 12 Month Forecast
Based on 13 Wall Street analysts offering 12 month price targets for C3ai in the last 3 months. The average price target is $26.45 with a high forecast of $40.00 and a low forecast of $19.00. The average price target represents a 15.00% change from the last price of $23.00.
Average Price Target
Based on 4 Wall Street analysts offering 12 month price targets for Solaris Resources in the last 3 months. The average price target is C$11.71 with a high forecast of C$14.01 and a low forecast of C$6.83.
DeFi applications are designed to communicate with a blockchain, allowing people to use their money for purchases, loans, gifts, trading, or any other way they want without a third party. These applications are programs installed on a device like a personal computer, tablet, or smartphone that make it easier to use.
What is the target price for LYTs stock? ›The average price target is $19.67 with a high forecast of $21.00 and a low forecast of $18.00.
What is the 12 month price target for NIO? ›Analyst Price Targets
Based on analysts offering 12 month price targets for NIO in the last 3 months. The average price target is $5.97 with a high estimate of $8 and a low estimate of $4.
| Year | Price Target | % Change From Current Price |
|---|---|---|
| 2024 | $6.94 | Upside of 25.05% |
| 2025 | $6.63 | Upside of 19.46% |
| 2026 | $7.80 | Upside of 40.54% |
| 2027 | $13.80 | Upside of 148.65% |
(NYSE: NIO) Nio's forecast annual revenue growth rate of 33.82% is forecast to beat the US Auto Manufacturers industry's average forecast revenue growth rate of 9.47%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.32%. Nio's revenue in 2024 is $8,909,443,338.
What are the best AI stocks to buy in 2024? ›
| Ticker | Company | Performance (Year) |
|---|---|---|
| NVDA | NVIDIA Corp | 139.84% |
| PRCT | Procept BioRobotics Corp | 125.48% |
| SOUN | SoundHound AI Inc | 106.17% |
| ISRG | Intuitive Surgical Inc | 58.05% |
As for C3.ai, experts' forecasts range from $80 to $166 per share by 2025.
What is the best stock for artificial intelligence? ›| Ticker | Stock | YTD Performance |
|---|---|---|
| NVDA | Nvidia | 127.88% |
| MSTR | MicroStrategy Inc. | 105.86% |
| MSFT | Microsoft | 11.50% |
| GOOGL | Alphabet | 14.95% |
The average price target for Rex American Resources is $60.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $60.00 ,the lowest forecast is $60.00. The average price target represents 42.31% Increase from the current price of $42.16.
What is the stock price forecast for Inovio in 2025? ›On average, Wall Street analysts predict that Inovio Pharmaceuticals's share price could reach $19.00 by Aug 12, 2025. The average Inovio Pharmaceuticals stock price prediction forecasts a potential upside of 179% from the current INO share price of $6.81.
What is the ship stock prediction for 2025? ›According to analysts, SHIP price target is 14.25 USD with a max estimate of 15.00 USD and a min estimate of 13.00 USD.
What is the target price for IFRX stocks? ›What is IFRX price target? According to analysts, IFRX price target is 7.87 USD with a max estimate of 11.18 USD and a min estimate of 5.07 USD.
What is the target price for Tcbp stock? ›The average one-year price target for TC Biopharm (Holdings) Plc - Depositary Receipt (Common Stock) is $142.80. The forecasts range from a low of $141.40 to a high of $147.00. A stock's price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings.
What is the target price for Ionis stock? ›The average price target for Ionis Pharmaceuticals is $61.53. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $82.00 ,the lowest forecast is $37.00. The average price target represents 45.84% Increase from the current price of $42.19.
What is the target price for Cade stock? ›The average price target is $34.13 with a high forecast of $39.00 and a low forecast of $30.00. The average price target represents a 14.45% change from the last price of $29.82.